Atezolizumab Improves Survival Rate in Bladder Cancer Patients
Bladder cancer patients whose blood contained circulating tumour DNA (ctDNA), treated with the immunotherapy drug named Atezolizumab, responded well to the drug.
Stay updated with breaking news from Post Surgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bladder cancer patients whose blood contained circulating tumour DNA (ctDNA), treated with the immunotherapy drug named Atezolizumab, responded well to the drug.
Platform will enable patients to monitor and share updates of their post-surgical wound healing - News - PharmaTimes
A technique developed by the University of Birmingham demonstrates link between patients’ alpha brain waves and responses to pain - News - PharmaTimes
Predicting the likelihood of the transplant's success. >> a cold could kill you, covid could kill you. the organs are scarce. we're not going to distribute them to someone who has a very poor chance of living, when others who have vaccinated have a better chance post-surgery of surviving. >> erielle back with us tonight. we know this mask debate is happening all over the country with omicron having peaked in some places. hopefully peaking in other places in the coming weeks. and that news tonight on that new york appeals court judge keeping the mask mandate in effect for schools and businesses...
People who undergo facial surgery think their surgical scars look worse than surgeons and independent observers do, according to a recent study led by the University of Pennsylvania.